six candidate genes by real-time polymerase chain reaction quantitation analysis of four GBM samples. Investigation of these genes should help provide important insights into the biological mechanisms at work, facilitate identification of tumors that are susceptible or resistant to radiation therapy and aid in the design of approaches to enhance specifically the radiosensitivity of these deadly neoplasms.
Gene expression profiles at various stages of lymphomagenesis in Em-myc transgenic mice
Carla Grandori, Brian Iritani & Robert Eisenman
Fred Hutchinson Cancer Research Center, Seattle, Washington, USA
To define molecular signatures of c-myc-induced B-cell neoplasias we have explored, using DNA microarrays, gene expression profiles at various stages of tumorigenesis utilizing the transgenic Em-myc model 1 . In this system c-myc is expressed, under the control of the immunoglobulin heavy-chain enhancer, selectively in B-cell precursors, and it causes the rapid appearance of B-cell lymphomas. Overt tumors are preceded by a marked polyclonal expansion of pre-B cells both in the bone marrow and in the spleen. However, these cells are not yet tumorigenic. Within a few months the Em-myc mice develop a monoclonal or oligoclonal lymphoma. We monitored gene expression changes using an 11,000-gene chip (Affymetrix) of pre-B cells derived from the bone marrow of Em-myc mice before tumor development and cells from lymphomas, consisting primarily of pre-B cells. Both samples were then compared with normal pre-B lymphocytes obtained from bone marrow of wild-type mice. The data analysis allowed a display of gene expression changes that accompany these various stages of tumor development. Preliminary results indicate that specific signaling pathways are selectively altered in the tumor samples or in the hyperplastic pre-B cells. In addition, comparison of the pre-B cells expressing Em-myc with wild-type pre-B cells highlighted gene expression changes that might be direct consequences of deregulated c-myc expression and therefore provided new candidate Myc target genes. We will present a discussion of the relevance of our study for the understanding of c-myc-induced tumorigenesis.
1. Adams, J.M. et al. Nature 318, 533-538 (1985) .
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Analysis of gene expression alterations in mouse and human hepatocellular carcinomas Although each comparison revealed hundreds of differentially expressed genes, only 22 genes were found to be deregulated in the tumors in all three comparisons. We also employed representational difference analysis to clone fragments of messenger RNAs differentially expressed in liver tumors versus regenerating livers. Although many of the same mRNAs were identified as in the oligonucleotide microarray experiments, we also cloned several new mRNAs that are differentially regulated in liver tumors. We have cloned the mouse complementary DNA of novel 4 and are currently isolating the human homologue of this unknown gene. We are using representational difference analysis and oligonucleotide microarrays to identify genes whose expression is deregulated in the development of human hepatocellular carcinomas. Using these models and techniques, we hope to identify common genetic alterations in the progression of liver cancer in both humans and mice.
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